Trials / Enrolling By Invitation
Enrolling By InvitationNCT05744713
An Observational Study of Patients With Chronic Liver Disease
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 500,000 (estimated)
- Sponsor
- Target PharmaSolutions, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational | Observational |
Timeline
- Start date
- 2024-02-19
- Primary completion
- 2037-12-31
- Completion
- 2037-12-31
- First posted
- 2023-02-27
- Last updated
- 2026-03-03
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05744713. Inclusion in this directory is not an endorsement.